Experimental cell therapy aims to reset immune system in Tough-to-Treat lupus
NCT ID NCT07328581
Summary
This early-stage trial is testing a new type of cell therapy for people with severe systemic lupus erythematosus (SLE) that hasn't improved with standard treatments. Researchers will collect a patient's own immune cells, modify them in a lab to better target the cells causing lupus, and then infuse them back. The main goals are to see if this one-time treatment is safe and if it can put lupus into remission without needing ongoing lupus medications.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SYSTEMIC LUPUS ERYTHEMATOSUS (SLE) are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.